FREE COLD-CHAIN SHIPPING OVER $250 · THIRD-PARTY TESTED · 98%+ PURITY · FREE COLD-CHAIN SHIPPING OVER $250 · THIRD-PARTY TESTED · 98%+ PURITY · FREE COLD-CHAIN SHIPPING OVER $250 · THIRD-PARTY TESTED · 98%+ PURITY · FREE COLD-CHAIN SHIPPING OVER $250 · THIRD-PARTY TESTED · 98%+ PURITY ·
WEIGHT MANAGEMENT & METABOLIC HEALTH · RESEARCH GRADE

Retatrutide

98%+ Purity In Stock SKU: RT
Price range: $100.00 through $470.00
Next Generational Triple Hormone Peptide Therapy
❄ Cold-Chain Shipped 📄 COA Included ⚡ Ships in 48h
Purity98%+
FormLyophilized Powder
Storage−20°C
OriginSwitzerland

About this compound

Retatrutide

Retatrutide is a next-generation investigational peptide developed to target three key metabolic hormone pathways simultaneously — GLP-1, GIP, and glucagon receptors — to deliver unmatched results in weight management, metabolic control, and overall wellness support. Its unique triple-agonist mechanism is designed to optimize appetite regulation, boost energy expenditure, and improve glycemic balance more effectively than traditional single- or dual-hormone therapies.

Key Benefits of Retatrutide

• Substantial Weight Loss: Up to ~24% body-weight reduction in clinical studies.
• Enhanced Metabolic Health: Improved insulin sensitivity, reduced fasting glucose, and decreased HbA1c.
• Liver Health: Up to 81–86% reduction in liver fat content.
• Comprehensive Wellness: Favourable changes in adiponectin, leptin, triglycerides, and waist circumference.

Clinical Highlights of Retatrutide

• Study: 48-week, double-blind, placebo-controlled Phase 2 trial
• Results: ~22.8% weight loss (8 mg dose), ~24.2% weight loss (12 mg dose)
• ~0.9% HbA1c reduction
• Significant improvements in cardiometabolic risk factors

Safety & Tolerability

• Most common side effects: nausea, vomiting, diarrhea, abdominal discomfort, constipation — typically mild to moderate and
dose-dependent.
• Serious adverse events: Rare and comparable to placebo when dosing is titrated gradually.
• Ongoing monitoring recommended for pancreatitis, gallbladder events, or potential long-term effects.

Dosing

• Administered as a once-weekly subcutaneous injection.
• Studied doses: 1 mg, 4 mg, 8 mg, 12 mg.
• Optimal results seen at 8 mg–12 mg with titration to improve tolerability.

• No approved dosing regimen currently exists — investigational use only.

All information provided is for informational and research reference purposes only and should not be interpreted as medical advice. NordWellness makes no claims regarding therapeutic use or outcomes.
YOU MAY ALSO NEED

Related Compounds

See all →
MOTS-c 10mg

MOTS-c 10mg

Mitochondrial-Derived Peptide for Metabolic and Cellular Health

0.11lbs $60.00
Add to cart
5-amino-1mq 5mg

5-amino-1mq 5mg

Innovative Small Molecule for Metabolic and Cellular Health

0.11lbs $80.00
Add to cart